1,258 results on '"BORDIGNON , CLAUDIO"'
Search Results
2. R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma
3. Robust in vivo Gene Transfer into Adult Mammalian Neural Stem Cells by Lentiviral Vectors
4. Twenty-five years of gene therapy for genetic diseases and leukemia: The road to marketing authorization of the first ex vivo gene therapies
5. Vectofusin-1 Promotes RD114-TR-Pseudotyped Lentiviral Vector Transduction of Human HSPCs and T Lymphocytes
6. Correction of ADA-SCID by Stem Cell Gene Therapy Combined with Nonmyeloablative Conditioning
7. Codon Optimization Leads to Functional Impairment of RD114-TR Envelope Glycoprotein
8. Dendritic Cells Acquire the MAGE-3 Human Tumor Antigen from Apoptotic Cells and Induce a Class I-Restricted T Cell Response
9. Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells
10. HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-Leukemia
11. 24-Hydroxycholesterol participates in pancreatic neuroendocrine tumor development
12. RD-MolPack technology for the constitutive production of self-inactivating lentiviral vectors pseudotyped with the nontoxic RD114-TR envelope
13. Supplementary Methods, Figures Legends 1-7 from De Novo Design of a Tumor-Penetrating Peptide
14. Supplementary Figure 1 from De Novo Design of a Tumor-Penetrating Peptide
15. Supplementary Figure 6 from De Novo Design of a Tumor-Penetrating Peptide
16. Data from De Novo Design of a Tumor-Penetrating Peptide
17. Supplementary Table 1 from De Novo Design of a Tumor-Penetrating Peptide
18. Supplementary Figure 7 from De Novo Design of a Tumor-Penetrating Peptide
19. Supplementary Figure 2 from De Novo Design of a Tumor-Penetrating Peptide
20. Supplementary Figure 1 from Isoaspartate-Glycine-Arginine: A New Tumor Vasculature–Targeting Motif
21. Supplementary Figure 3 from De Novo Design of a Tumor-Penetrating Peptide
22. Supplementary Figure 1 Legend from Isoaspartate-Glycine-Arginine: A New Tumor Vasculature–Targeting Motif
23. Supplementary Figure 5 from De Novo Design of a Tumor-Penetrating Peptide
24. Supplementary Figure 4 from De Novo Design of a Tumor-Penetrating Peptide
25. Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation
26. The IL-1/IL-1 receptor axis and tumor cell released inflammasome adaptor ASC are key regulators of TSLP secretion by cancer associated fibroblasts in pancreatic cancer
27. The administration of drugs inhibiting cholesterol/oxysterol synthesis is safe and increases the efficacy of immunotherapeutic regimens in tumor-bearing mice
28. CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma
29. Graft-versus-leukemia Effect of HLA-haploidentical Central-memory T-cells Expanded With Leukemic APCs and Modified With a Suicide Gene
30. IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors
31. Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy
32. T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation
33. A dual role for genetically modified lymphocytes in cancer immunotherapy
34. IL-7 receptor expression identifies suicide gene–modified allospecific CD8+ T cells capable of self-renewal and differentiation into antileukemia effectors
35. Retroviral Vector Integration Deregulates Gene Expression but Has No Consequence on the Biology and Function of Transplanted T Cells
36. Phase II study of NGR-hTNF, a selective vascular targeting agent, in patients with metastatic colorectal cancer after failure of standard therapy
37. Defining the optimal biological dose of NGR-hTNF, a selective vascular targeting agent, in advanced solid tumours
38. Peripheral blood lymphocytes genetically modified to express the self/tumor antigen MAGE-A3 induce antitumor immune responses in cancer patients
39. IL-7 and IL-15 allow the generation of suicide gene–modified alloreactive self-renewing central memory human T lymphocytes
40. Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study
41. An in Vivo Model of Somatic Cell Gene Therapy for Human Severe Combined Immunodeficiency
42. Hematopoietic Histoincompatibility Reactions by NK Cells in vitro: Model for Genetic Resistance to Marrow Grafts
43. Gene Therapy in Peripheral Blood Lymphocytes and Bone Marrow for ADA$^-$ Immunodeficient Patients
44. Retroviral Vector-Mediated High-Efficiency Expression of Adenosine Deaminase (ADA) in Hematopoietic Long-Term Cultures of ADA-Deficient Marrow Cells
45. Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer
46. Temporal, quantitative, and functional characteristics of single-KIR–positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation
47. Structural Basis for the Interaction of isoDGR with the RGD-binding Site of αvβ3 Integrin
48. Altered intracellular and extracellular signaling leads to impaired T-cell functions in ADA-SCID patients
49. Tumor-mediated liver X receptor-α activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses
50. Loss of mismatched HLA in leukemia after stem-cell transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.